Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Craig Fraser | President and CEO | 2024-10-08 | 5,431 | $0.91 | $4.94kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Lph Investments Ltd | 1,300.13% | 46,232,085 | $49.93M | Insider |
Lees Pharmaceutical Holdings Ltd | 488.50% | 17,370,770 | $18.76M | Insider |
China Cardiovascular Focus Ltd | 226.77% | 8,063,861 | $8.71M | Insider |
James Huang | 173.02% | 6,152,576 | $6.64M | Insider |
Panacea Venture Healthcare Fund I LP | 127.32% | 4,527,345 | $4.89M | Insider |
Ivy Blue Holdings Ltd | 121.96% | 4,336,790 | $4.68M | Insider |
Lph II Investments Ltd | 112.72% | 4,008,234 | $4.33M | Insider |
Center Laboratories Inc | 69.69% | 2,478,176 | $2.68M | Insider |
Robert J. Capetola | 12.27% | 436,417 | $471.33k | Insider |
Christopher J. Schaber | 6.55% | 232,771 | $251.39k | Insider |